The Open Directory Project.

Directory of Lapatinib Resources

Home > Health > Pharmacy > Drugs and Medications > L > Lapatinib

Lapatinib is classified as a signal transduction inhibitor - tyrosine kinase inhibitor, inhibitor of EGFR and HER2. Lapatinib is marketed as Tykerb and is used in the treatment of metastatic breast cancer that is HER-2 positive. The drug may also be used in combination with other chemotherapy drugs or for the treatment of other cancers.

Resources in This Category

Related Categories

 

Home > Health > Pharmacy > Drugs and Medications > L > Lapatinib

 


 

Thanks to DMOZ, which built a great web directory for nearly two decades and freely shared it with the web. About us